Trials / Completed
CompletedNCT02507336
Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165
Long-term Follow-up and/or Continued Thalidomide (THALOMID®) Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study seeks to provide long-term follow-up and/or to offer continued maintenance thalidomide (THALOMID) therapy to those patients enrolled in 20030165. Patients will be followed until withdrawal of consent, or death.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Thalidomide | 100-300 mg capsule taken by mouth once daily. |
Timeline
- Start date
- 2015-11-24
- Primary completion
- 2023-08-02
- Completion
- 2023-08-02
- First posted
- 2015-07-23
- Last updated
- 2024-08-01
- Results posted
- 2024-08-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02507336. Inclusion in this directory is not an endorsement.